ASH 2017: CLL Combination Therapy News

ASH 2017: CLL Combination Therapy News

P2Professional

1 year
1,056 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Can todays medicines be used together to treat CLL more effectively? CLL expert Dr. Michael Choi of UC San Diego Moores Cancer Center joins Patient Powers Andrew Schorr at the 2017 American Society of Hematology (ASH) conference. Dr. Choi provides an update on current medicines and discusses promising combination therapies for CLL, including research into combining ibrutinib (Imbruvica) and venetoclax (Venclexta).
Up Next Autoplay
New Technology to Streamline Drug Discovery
New Technology to Streamline Drug Discovery
Category: Other
2 Views
Cancer-News 11 hours
Using Technology to Better Understand What Goes Wrong in Cancer
Using Technology to Better Understand What Goes Wrong in Cancer
Category: Breast Cancer
0 Views
Cancer-News 12 hours
How Does This Affect Clinicians Today?
How Does This Affect Clinicians Today?
Category: Breast Cancer
1 Views
Cancer-News 12 hours
Measuring Chromatin Accessibility: How Reliable is This Data?
Measuring Chromatin Accessibility: How Reliable is This Data?
Category: Breast Cancer
0 Views
Cancer-News 12 hours
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Category: Melanoma and Skin Cancer
3 Views
Cancer-News 13 hours
Mapping the usual breast development to recognize cancer better
Mapping the usual breast development to recognize cancer better
Category: Breast Cancer
2 Views
Cancer-News 14 hours
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
3 Views
Cancer-News 14 hours
New Frontier Possibility for Preventing Ovarian Cancer
New Frontier Possibility for Preventing Ovarian Cancer
Category: Ovarian Cancer
2 Views
Cancer-News 15 hours
"Wild idea" opens possible new boundaries to ovarian cancer prevention
Category: Ovarian Cancer
5 Views
Cancer-News 15 hours
Personalized Algorithms: How is this different?
Personalized Algorithms: How is this different?
Category: Immunotherapy
4 Views
Cancer-News 1 day